Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

  1. Pascual, T.
  2. Oliveira, M.
  3. Villagrasa, P.
  4. Ortega, V.
  5. Paré, L.
  6. Bermejo, B.
  7. Morales, S.
  8. Amillano, K.
  9. López, R.
  10. Galván, P.
  11. Canes, J.
  12. Salvador, F.
  13. Nuciforo, P.
  14. Rubio, I.T.
  15. Llombart-Cussac, A.
  16. Di Cosimo, S.
  17. Baselga, J.
  18. Harbeck, N.
  19. Prat, A.
  20. Cortés, J.
Aldizkaria:
npj Breast Cancer

ISSN: 2374-4677

Argitalpen urtea: 2021

Alea: 7

Zenbakia: 1

Mota: Artikulua

DOI: 10.1038/S41523-021-00351-4 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus